Literature DB >> 35059780

Assessment of Exercise Function in Children and Young Adults with Hypertrophic Cardiomyopathy and Correlation with Transthoracic Echocardiographic Parameters.

Robert Przybylski1, Ilana R Fischer2, Kimberlee Gauvreau2, Mark E Alexander2, Keri M Shafer2, Steven D Colan2, Christa Miliaresis3, Jonathan Rhodes2.   

Abstract

Exercise function is well characterized in adults with hypertrophic cardiomyopathy (HCM); however, there is a paucity of data in children and young adults with HCM. Here we sought to characterize exercise function in young people with HCM, understand limitations in exercise function by correlating exercise function parameters with echocardiogram parameters and identify prognostic value of exercise parameters. We performed a retrospective, single-center cohort study characterizing exercise function in patients < 26 years old with HCM undergoing cardiopulmonary exercise testing (CPET). Patients with syndromic HCM or submaximal effort were excluded. We compared exercise function in this cohort to population normal values and measured changes in exercise function over time. We correlated exercise function parameters with echocardiographic parameters and investigated the relationship between exercise test parameters and a clinical composite outcome comprised of significant ventricular arrhythmia, death, or heart transplantation. We identified 229 CPETs performed by 117 patients (mean age at time of first CPET 15.6 ± 3.2 years). Mean %-predicted peak VO2, O2 pulse, and peak heart rate were statistically significantly depressed compared to population normal values and exercise function gradually worsened over time. Abnormal exercise testing correlated closely with echocardiographic indices of diastolic dysfunction. There was a trend toward increased incidence of poor clinical outcome in patients with abnormal exercise function. While adverse clinical outcomes were rare, normal exercise function appears to be a marker of low risk for adverse clinical outcomes in this population.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiopulmonary exercise testing; Diastolic dysfunction; Hypertrophic cardiomyopathy; Pediatric cardiology

Mesh:

Year:  2022        PMID: 35059780     DOI: 10.1007/s00246-022-02822-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

Review 1.  Hypertrophic cardiomyopathy in childhood.

Authors:  Steven D Colan
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

2.  Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study.

Authors:  Hiroyuki Morita; Martin G Larson; Scott C Barr; Ramachandran S Vasan; Christopher J O'Donnell; Joel N Hirschhorn; Daniel Levy; Diane Corey; Christine E Seidman; J G Seidman; Emelia J Benjamin
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

3.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

Authors:  J A Panza; R K Petrone; L Fananapazir; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

4.  Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Filippo Maria Cauti; Beatrice Musumeci; Gabriele Egidy Assenza; Carlo Nicola De Cecco; Giuseppe Muscogiuri; Antonello Maruotti; Agnese Ricotta; Erika Pagannone; Laura Marino; Daria Santini; Giulia Proietti; Andrea Serdoz; Francesco Paneni; Massimo Volpe; Camillo Autore
Journal:  Intern Emerg Med       Date:  2012-10-07       Impact factor: 3.397

5.  Mechanism of mitral regurgitation in hypertrophic obstructive cardiomyopathy.

Authors:  R B Pridie; C M Oakley
Journal:  Br Heart J       Date:  1970-03

6.  Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities.

Authors:  B J Maron; R Mathenge; S A Casey; L C Poliac; T F Longe
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

7.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy.

Authors:  S Sharma; P Elliott; G Whyte; S Jones; N Mahon; B Whipp; W J McKenna
Journal:  Am J Cardiol       Date:  2000-07-15       Impact factor: 2.778

8.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

9.  Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics.

Authors:  S S Lele; H L Thomson; H Seo; I Belenkie; W J McKenna; M P Frenneaux
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

10.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults.

Authors:  Yubao Zou; Lei Song; Zhimin Wang; Aiqun Ma; Tangwei Liu; Huimin Gu; Sailan Lu; Pengzhu Wu; Ying Zhang dagger; Li Shen dagger; Yuling Cai; Yisong Zhen double dagger; Yanling Liu; Rutai Hui
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.